Ana-Mishel Spiroski

Scopus Author ID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Skeletal Muscle

Long Noncoding Rna

Body Composition

Top Venues

American journal of physiology. Endocrinology and metabolism

Hypertension (Dallas, Tex. : 1979)

International journal of molecular sciences

University of Edinburgh

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Edinburgh

United Kingdom

Postdoctoral Research Fellow :: Centre for Cardiovascular Science

University of Cambridge

United Kingdom

Postdoctoral Research Associate :: Medicine, Division of Experimental Medicine and Immunotherapeutics

University of Cambridge

United Kingdom

Postdoctoral Research Associate :: Physiology, Development & Neuroscience

University of Auckland

New Zealand

Postdoctoral Research Associate :: LENScience, The Liggins Institute

Publications

Rama Lakshman, Ana-Mishel Spiroski, Lauren B McIver, Michael P Murphy, Dino A Giussani
Noninvasive Biomarkers for Cardiovascular Dysfunction Programmed in Male Offspring of Adverse Pregnancy. Hypertension (Dallas, Tex. : 1979) 78 (6) (2021)
Emma J Buckels, Frank Harry Bloomfield, Mark H Oliver, Ana-Mishel Spiroski, Jane E Harding, Anne L Jaquiery
Sexually dimorphic changes in the endocrine pancreas and skeletal muscle in young adulthood following intra-amniotic IGF-I treatment of growth-restricted fetal sheep. American journal of physiology. Endocrinology and metabolism 321 (4) (2021)
Ana-Mishel Spiroski, Rachel Sanders, Marco Meloni, Ian R McCracken, Adrian Thomson, Mairi Brittan, Gillian A Gray, Andrew H Baker
The Influence of the LINC00961/SPAAR Locus Loss on Murine Development, Myocardial Dynamics, and Cardiac Response to Myocardial Infarction. International journal of molecular sciences 22 (2) (2021)
Ana-Mishel Spiroski, Mark Hope Oliver, Anne Louise Jaquiery, Travis Dane Gunn, Jane Elizabeth Harding, Frank Harry Bloomfield
Effects of intrauterine insulin-like growth factor-1 therapy for fetal growth restriction on adult metabolism and body composition are sex specific. American journal of physiology. Endocrinology and metabolism 318 (4) (2020)